ReviewFrontiers in medicine2026

Efficacy analysis and adverse event management of selinexor in the treatment of relapsed/refractory multiple myeloma.

Zengli Kuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.